Patients may experience redness, swelling, or mild pain at injection sites
These two targeted iFIT programs offer guided paths to protect your muscle and support your long-term success
[DOI] [PubMed] [Google Scholar] 144.Nicolau J., Tamayo M.I., Sanchis P., Pujol A., Perez-Bec G., Sfondrini G., Masmiquel L
This builds on his work to understand 'how circulating GLP-1 can produce multiple actions, both directly and indirectly, on multiple organs' which he has pursued for many years with colleagues (McLean, Wong, Campbell)
If the GLP-1/GIP/glucagon receptor class shows disease-modifying behaviour in OA rather than just mechanical pain relief from weight loss, it expands the scientific rationale for the compound and reinforces the argument that the triple-agonist mechanism is doing more than suppressing appetite
In TRIUMPH-4 (obesity + knee OA): nausea 43%, diarrhea 33%, vomiting 21%, constipation 25%, dysesthesia 20.9%